A week of kanamycin gel treatment before and after the placement of dental restorations, compared to a placebo gel treatment, significantly reduced the levels of cultivable bacteria, S mutans and S sanguis, in the plaque samples collccted immediately after the completion of the gel treatments, and was associated with a 46% reduction in new carious surfaces in the 14-to 37-month period following the gel treatment.
A week of kanamycin gel treatment before and after the placement of dental restorations, compared to a placebo gel treatment, significantly reduced the levels of cultivable bacteria, S mutans and S sanguis, in the plaque samples collccted immediately after the completion of the gel treatments, and was associated with a 46% reduction in new carious surfaces in the 14-to 37-month period following the gel treatment.
Dental decay caused by Streptococcus mtutans can be prevented or significan>ly reduced in aninal models by the prolonged administration of antibiotics in food and/or water.1 This treatment regimen is not applicable to human beings because of the problems associated with longterm antibiotic therapy`and the impracticality of adding antibiotics to food and water for human consumption. Short-term applications of vancomycin, given topically in a gel, will lower the proportions of S mutans in human plaque.3 When vancomycin was given daily during the school year, the levels of S mutans and number of carious surfaces decreased slightly, but significantly, compared to a group receiving no treatment.5-6 Short-term application of kanamycin, given topically in Orabase, significantly reduced plaque weight and gingivitis scores in institutionalized patients when compared with the placebo treatment.7 Tbe plaque in the kanamycin-treated patients had significantly fever streptococci than did the plaque in the placebo-treated group.8 In the present investigation, the effect of short-term application of kanamycin or placebo gels on the plaque levels of S mutans and Streptococcus sanguis and on subsequent caries experience was assessed in children and teenagers diagnosed as having both rampant caries and elevated plaque levels of S mutans. entcred the study per month. Thirty-one patients completed both weeks of gel treatment; 29 of these returned for recall appointments over the next 14-to 37-month period.
DIAGNOSIS OF CARIESO-A clinical examination -with ani explorer alnd full mouth x-ray films were used to enumerate the number of de- cay ed surfaces at the initial visit (Table 1) . Any questionable lesions were considered as carious.
However, after completion of restorative and gel treatmcnt, only sites where cavitation occurred were diagnosed as being carious. In some instances, this amounted to watching the progres- sion of a lesion over one or more recall visits to the sta,e where it was frankly carious.
TREATMENT.-All patients received the restorative dentistry, consisting of amalgams and stainless steel crowns, that was necessary to debride their teeth of decayed tissue. This phase of treatment took from four to seven weeks. In addition to this usual mechanical treatment, the patients were assigned, on a double blind basis, to the kanamycin or placebo gel treatment. The gel treatment was given for a one-week period immediately prior to the start of the restorative dentistry and for a second week immediately following the completion of the restorative dentistry (Table 1 ). The patient and/or his or her parent were shown how to apply the gel to standardized plastic trays (Fluoratray, Kerr, Romulus, Mi) and to insert the trays laden with gel into the patient's mouth. They were instructed to insert these trays for approximately five minutes in the morning after breakfast and for five minutes in the evening just before retiring.
The patients wvere given a week's supply of gel and trays and were reques'-ed to record any noncompliance with these instructions. The actual usage of the gels was unsupervised. The patients and their parents were fully informed that they were receiving either a prescription drug or placebo drug. Approximately 10 to 15 minutes of office time was spent in this instruct>on and demonstration of the gel application.
The gels contained 1.4% hydroxyethyl cellulose, 0.24% methyl paraben, 0.04% propyl paraben, 0.2% sodium saccharin, coloring and flavoring agents and water (Davies, Rose Hoyt Pharmaceutical Co., Needham, Ma). The placebo gel was used as such, whereas 5% kanamycin sulfate (Kantrex, Bristol Laboratories, Syracuse, NY) was added to the kanamycin gel. The kanamycin gel was prepared by stirring the powdered drug into the gel and then further dispersing with a sonifier. The gels were evaluated for their minimal inhibitory concentration against plaque bacteria periodically during the study and exhibited no loss of potency. The addition of kanamycin to the gel caused no apparent change in the taste of the gel. BACTERIOLOGY. The following bacteriological specimens were obtained before and after each gel treatment and at the various recall visits (Table 1) . Unstimulated saliva was collected bv expectoration into a wide mouth bottle and 1 ml was placed into 9 ml of reduced transport fluid (RTF).9,10 Fissure plaque was obtained by forcibly scratching the fissure depths of the most distal tooth in each quadrant wiLh a sterile pointed wire held with a sterile hemostat.1" A separate wire was used to sample each of the four teeth. All four wires were placed into the same 10 mls of RTF, so that this specimen represented a pooling of fissure plaque from the four molar areas of the mouth. Approximal plaque was collected from the most distal interproximal site in each quadrant by All samples were brought to the laboratory within one to four hours after collection. They were dispersed for five to ten seconds by sonification, serially diluted, and appropriate dilutions plated in duplicate on MM1O sucrose agar (plaque samples)12,13 and MSB agar (plaque and salivary samples).14 The plates were incubated for four to seven days at 37 C in an atmosphere of 85% N2, 10% H2, and 5% CO2. The total colony forming units (CFU), S mutans and S sanguis colonies on the MM10 sucrose plates and the S mutans counts on the MSB plates were enumerated. Representative S mutans colonies were tested for mannitol fermentation.
STATISTICS.-The S mutans counts on both media and the S sanguis counts on the MM10 sucrose medium were normalized as a percentage of the total CFU on the MM1O sucrose medium for each plaque sample. The S mutans count in saliva was recorded per ml of saliva. The absolute and/or percent normalized data for the plaque and salivary samples for the 2 treatment gels were compared by computer using the MIDAS statistical programs available in the Michigan Terminal System. The data were tested for significance by both the parametric t test and the nonparametric median and Kruskal Wallis Test.15
Results
The S mutans counts on the MM10 sucrose agar were consistently higher than those on MSB agar. In 510 samples that were cultured on both media, the MM10 sucrose counts were noticeably higher in 46% of the comparisons, i.e., the S mutans count on MM10 was at least 10 CFU higher than that on MSB agar; were approximately equal in 37% of the comparisons, i.e., the coulnt of S mutans on MM10 sucrose agar and MSB were within 10 CFU of each other; and were noticeably lower in 17% of the comparisons, i.e., .he S mutans count on MSB was at least 10 CFU higher than that on MM10 sucrose.
Forty-five patients received the first gel treatment and 31 received the second gel treatment. There were no complaints concerning taste of the gels and use of trays. All patients reported that they used the gels according to instructions.
The first gel treatment was given while open carious lesions were present in the mouth. The kanamycin gel lowered the levels of S J Dent Res March 197; mutans in the plaques and saliva relative to the placebo gel (Table 2) . This difference between groups was significant for the fissure plaques. Within the kanamycin group, the antibiotic gel caused a significant fivefold decrease in the fissure levels of S mutans, but only slight edecreases in the approximal and salivary levels of S mutans (Table 2) . Within the placebo group, the gel treatment was associated with an appreciable increase in plaque levels of S mutans.
Dental restorations were placed in the patient's teeth during the next four to seven weeks.
At their completion, the restorations were polished and the bacteriological samples collected. In both groups, the salivary levels of S mutans had decreased to about 15 X 104 organisms per ml of saliva ( Table 2 ). The approximal levels of S mutans were not significantly higher in the kanamycin group, whereas the fissure levels were comparable in both groups. The gels were given for a second one-week period. The kanamycin gel reduced the approximal levels of S mutans threefold, the fissure levels 16-fold and the salivary levels fourfold relative to the before-treatment values ( (Table 5 ). After the first gel treatment, the total counts and S sanguis counts of the approximal and fissure plaques were significantly lower in the kanamycin group. The fissure levels of S mutans decreased significantly, but there was no alteration in the approximal levels. These changes resulted in a significant increase in the proportions of S mutans and the mutanssanguis (MS) ratio in the approximal plaques. After the placement of dental restorations, the total count and S mutans counts in the approximal plaques were significantly higher and the S sanguis counts significantly lowAer in the kanamycin group. No significant differences were observed at this time in the fissure plaques. After the second gel treatment, all the median values decreased. The kanamycin subjects had significantly lowel counts in all samples except for the S mutans counts in the approximal plaques. When the percent normalized values were compared, the percent S mutans and the MS ratio increased significantly and the percent S sanguis decreased significantly in the approximal plaques. No changes in the proportions of S mutans and S sanguis were observed in the fissure plaques. The results indicated that the kanamycin treatment was effective in reducing the bacterial count in fissure and approximal plaque samples. However, the significantly higher proportions of S mutans and the higher MS ratio in approximal plaques of the kanamycin-treated subjects were considered undesirable. The clinical findings on the first few patients at the nine-month recall visit indicated that the number of new carious lesions was higher in the kanamycintreated patielts. A decision was made to stop the entry of new patients into the study and to continue to observe, at recall visits, the plaque levels of S mutans and S sanguis as well as the new caries experience of the patients already in the study.
Twenty-nine patients returned for four or more recall visits in the 14-to 37-month period following the second gel treatment. There were no discernible differences at the time of entry into the study between the 16 kanamycin and the 13 placebo patients as to age, and bacteriological status (Tables 6). The number of sound surfaces at risk after the completion of the operative dentistry was remarkably similar for both groups (Table 6 ). The second kanamycin treatment in this group of patients had significantly reduced the plaque levels of S mutans, S sanguis, and other cultivable bacteria relative to the placebo treatment (Tables 7 and  8) . However, at the two-to four-month recall visit and at all subsequent recall visits during the first year the initial diffeirences between the groups disappeared (Tables 7 and 8 ). There was an unexplained significant decrease in fissure S mutans levels in the placebo group at the two-to four-month recall visit (Table 7) . Otherwise no significant differences were observed. The salivary levels of S mutans ranged from 10.5 to 45.6 X 104 organisms/ml of saliva at the various recall visits with no differences observed between the treatment groups.
The caries experience of the subjects differed according to the gel treatment. Eight of 16 kanamycin subjects and 9 of 13 placebo subjects developed carious lesions during the 14 to 37 months following gel treatment ( Table 9 ). The three patients who developed the highest number of new carious lesions were in the placebo group. A total of 30 lesions was detected in the kanamycin-treated patients and 45 in the placebo patients. In both groups approximately 64% of the lesions occurred on the fissure surfaces, 25% on the approximal surfaces, and 11 % on the smooth surfaces (Table 10 ). Fissure caries were first observed in the placebo group at the six-month recall visit, and in the kanamycin group at the nine-month recall visit (Table 10) . At the nine-month recall visit, the kanamvcin patients had seven times the number of new carious surfaces than the placebo patients (Fig 1) . Thereafter, the incidence of caries increased in the placebo group, so that after 15 to 16 months the total number of carious surfaces was higher in this group and continued so for the remainder of the observation period. The placebo group averaged 3.46 carious surfaces per subject, whereas the kanamycin group averaged 1.88 carious surfaces. This represents about a 46% reduction of new carious surfaces in the kanamycin group when compared with the placebo gToup. This reduction was distributed among the surfaces as follows: 47% on the fissure surfaces, 41% on the approximal surfaces, and 50% on the smooth suffaces (Table 10 ). About 48% of the fissure surfaces at risk became carious in the kanamycin group, whereas 89% of the surfaces at risk became carious in the placebo group.
Discussion and Conclusions
The experimental protocol was based upon the specific plaque hypothesis2 that the presence of S mutans in high numbers in a plaque makes that plaque cariogenic. Individuals who had such S mutans dominated plaques were considered as having a specific infection that required intensive, but short-term antimicrobial treatment. A week of kanamnycin gel treatment prior to and after the placement of dental restorations, compared to a placebo gel treatment, significantly reduced the levels of cultivable bacteria, S mutans, and S sanguis in the plaque samples collected immediately after the completion of the gel treatments, and was associ- ated with a 46% reduction in new carious sur-system, such as dietary changes, the plaque faces in the 14-to 37-months period following levels of S mutans returned with time and apthe gel treatment. The initial bacteriological proached the placebo levels. This accounting differences between groups did not persist as does not suffice 'co explain how the short periods there was no apparent treatment effect in the of kanamycin therapy caused the appreciable plaque or saliva samples collected at any re-reductions in new carious lesions observed, nor call visit during the first year following treat-why 70% of the new carious surfaces in the ment. This would seem to indicate that the kanamycin group occurred by the nine-month changes brought by the kanamycin treatment recall visit (Fig 1) . The clinical findings indiwere inadequate to elimninate S mutans, and cate that kanamycin treatment accelerated the given no osher perturbations in the eco-rate of caries development on some surfaces, In this model, depicted in Fig 2, the tooth surface has three situations relative to health or disease: (1) the cariesfree surface, (2) the primary lesion, and (3) the secondary lesion of obvious cavitation. Each of these surfaces will respond differently to an effectively delivered antimicrobial agent. On the cariesfree surfaces the active agent will reduce the total number of bacteria, possibly eliminating S mutans as is shown in Fig 2 for kanamycin treatment. This agrees with the general reduction in viable count and S mutans seen following both periods of kanamycin therapy (Tables 2 and 3 ).
In the primary lesion, an antimicrobial agent may not penetrate to the deepest layers of plaque or enter into the demineralized zones, so that a nidus of bacteria consisting of those organisms at the advancing front of the lesion will survive. In the reformation of plaque, these bacteria could grow out of the lesion and comprise a higher proportion of the plaque flora (Fig 2) . In the present investigation, an enrichment for S mutans was found immediately after In the secondary lesion, an antimicrobial agent would behave in a manner similar to that described for the primary lesion. However, because of the cavitation associated with this lesion, it would be diagnosed as carious and debrided of carious tissue prior to the placement of a dental restoration. This should serve to reduce the levels of total organisms as well as S mutans. In the present investigation, the placement of dental restorations lowered the salivary and fissure levels of S mutans in all subjects (Tables 2 and 3 (Fig 2) , which would predict different treatment outcomes durinig the recall period. In the kanamycin groups, the cariesfree surfaces may be rid of an S mutans infection and stay that way during the recall period. Another investigation has shown that if disinfcction with iodine is successful in removing S mutans from a tooth surface, that surface may remain free of S mutans for a considlerable period of time following treatment.16 Thus, the cariesfree surfaces in the kanamycin group may remain that way because of the absence of, or low level of a S mutans infection. In the placebo group, the cariesfree surfaces would still contain S muans, and this fact might account for the eventLual development of caries on these surfaces during the recall visits. The primary lesion would also respond differently to the kanlamycin or placebo treatment. The kanamycin might kill plaque organisms on the surface, but would leave unaltered those organisms buried in the primary lesions found in fissures, and on approximal, and smooth surfaces. These residual organisms would dominate in the plaque which reforms on these surfaces, as described previously and depicted in Fig. 2 The model indicates that antimicrobial treatment prior to the placement of dental restorations or in the presence of primary and secondary lesionis will be counterproductive, as such treatment will select for organisms buried wvithin the lesions. If these organisms have cariogenic potential, such as S mutans, then an accelerated caries attack rate might ensue. The primary lesion in some, if not all cases, will be a zone of subsurface demineralization. An antimicrobial agent whicli is capable of penetrating into this zone might be the agent of choice. Topical fluerides promote remineralizationl7 and fluoride is found in elevated amounts in sites of arrested caries.'8 Accordingly, we have switched to short, intensive fluoride therapy, i.e., two times a day for one week in an effort to combat new carious lesions in these rapid caries patients. Preliminary data, obtained at the sixto nine-month recall visits, indicate the netutral 1.2% sodium fluoride is causing about a 50 to 60% reduction in caries relative to a placebo group (Loesche, Pink, and Woolfolk, unpublished data).
